申请人:Merck Sharp & Dohme Ltd.
公开号:US06479506B1
公开(公告)日:2002-11-12
Substituted or 6,7-ring fused 1,2,3-triazolo[4,5-b]pyridine derivatives are selective ligands for GABAA receptors useful in the treatment of disorders of the central nervous system.
取代或6,7-环融合的1,2,3-三唑[4,5-b]吡啶衍生物是选择性的GABAA受体配体,可用于治疗中枢神经系统疾病。